Outcome of hispanic patients treated with thrombolytic therapy for acute myocardial infarction
Mauricio G. Cohen(Santa Ana College), Robert M. Califf(Duke University), Marcelo V. Elizari(Hospital Ramos Mejía), Amadeo Betriu(Hospital Clínic de Barcelona), E. Magnus Ohman(Tarzana Treatment Centers), Eric J. Topol(Scripps Research Institute), David F. Kong(Clinical Research Institute), Arturo Cagide(Hospital Italiano de Buenos Aires), Amanda Stebbins(University of Alberta), Liliana Grinfeld(University of North Carolina at Chapel Hill), Christopher B. Granger(Clinical Research Institute)
Cited by 18
Related Papers
Long COVID: major findings, mechanisms and recommendations
|Nature Reviews Microbiology|2023|4k
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
|New England Journal of Medicine|2019|1.9k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
|Journal of the American College of Cardiology|2016|1.6k